Business Combinations (Tables)

6 Months Ended

Jul. 03, 2011

Jul. 01, 2012

Caliper Life Sciences [Member]

Business Acquisition [Line Items]

Fair Values of the Business Combinations and Allocations for the Acquisitions Completed

The total purchase price has been preliminarily allocated to the estimated fair values of assets acquired and liabilities assumed as follows:

	Caliper (Preliminary)
	(In thousands)
Fair value of business combination:
Cash payments	$	646,317
Less: cash acquired	(43,576		)
Total	$	602,741
Identifiable assets acquired and liabilities assumed:
Current assets	$	55,756
Property, plant and equipment	14,580
Identifiable intangible assets:
Core technology	52,000
Trade names	14,200
Licenses	18,000
Customer relationships	93,000
Goodwill	352,494
Deferred taxes	54,068
Deferred revenue	(7,825		)
Liabilities assumed	(43,532		)
Total	$	602,741

Business Acquisition, Pro Forma Information [Table Text Block]

The following unaudited pro forma information presents the combined financial results for the Company and Caliper as if the acquisition of Caliper had been completed as of January 2, 2011:

	Three Months Ended		Six Months Ended
	July 3, 2011		July 3, 2011
	(In thousands)
Pro Forma Statement of Operations Information (Unaudited):
Revenue	$	517,102	$	999,761
Net income from continuing operations	17,686		33,543
Basic earnings per share:
Continuing operations	$	0.16	$	0.30
Diluted earnings per share:
Continuing operations	$	0.16	$	0.29